Kinnate Biopharma(KNTE) - 2022 Q4 - Annual Report
Kinnate BiopharmaKinnate Biopharma(US:KNTE)2023-03-15 20:24

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 103 Montgomery Street, Suite 150 The Presidio of San Francisco San Francisco, CA 94129 (Address of principal executive offices) (Zip Code) Delaware 82-4566526 ☐ TRANSITION REPORT PURSUA ...